TrialJournal of clinical pharmacology2017

Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range.

Michael J Hanley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.